ID

18444

Descrizione

Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00491127

collegamento

https://clinicaltrials.gov/show/NCT00491127

Keywords

versioni (1)
  1. 05/11/16 05/11/16 -
Caricato su

5 novembre 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Non-Hodgkin's Lymphoma NCT00491127

Inglese

Eligibility Non-Hodgkin's Lymphoma NCT00491127

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patients must have a histological diagnosis of aggressive non-hodgkin’s lymphoma including the following sub-categories of the who classification:
Descrizione

Aggressive Non-Hodgkin Lymphoma | WHO tumor classification

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1332225
UMLS CUI [2]
C1301142
diffuse large b-cell lymphoma and its variants (immunoblastic, burkitt-like, sclerosis of mediastinum, large b-cell malt, rich in t-cells and anaplastic b-cell lymphoma)
Descrizione

Diffuse Large B-Cell Lymphoma | Immunoblastic Large-Cell Lymphoma | Burkitt-like lymphoma | Sclerosis Mediastinum | Mucosa-Associated Lymphoid Tissue Lymphoma | T-Cell Lymphoma | Anaplastic large B-cell lymphoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0079744
UMLS CUI [2]
C0079746
UMLS CUI [3]
C1368771
UMLS CUI [4,1]
C0036429
UMLS CUI [4,2]
C0025066
UMLS CUI [5]
C0242647
UMLS CUI [6]
C0079772
UMLS CUI [7]
C1321546
peripheral t-cell lymphoma
Descrizione

Peripheral T-Cell Lymphoma

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0079774
anaplastic lymphoma of large t-cells /null cells
Descrizione

Large cell anaplastic lymphoma T cell and Null cell type

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3838707
patients are eligible if they have documented evidence of progression after prior first-line chemotherapy containing anthracyclines associated or not with rituximab. patients with refractory disease to first line of treatment are also eligible.
Descrizione

chemotherapeutics regimen first line of treatment | Anthracyclines | rituximab | Disease Progression Evidence of | Refractory Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2045825
UMLS CUI [2]
C0282564
UMLS CUI [3]
C0393022
UMLS CUI [4,1]
C0242656
UMLS CUI [4,2]
C0332120
UMLS CUI [5]
C1514815
ecog ps (performance status) less than or equal to 2
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
presence of bidimensionally measurable disease in accordance with who criteria.
Descrizione

Measurable Disease 2-Dimensional

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1705052
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
involvement of the cns.
Descrizione

Central Nervous System Involvement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4050309
any medical condition which contraindicates the degree of hydration required for the safe use of cisplatin.
Descrizione

Medical condition Contraindication Cisplatin

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C1301624
UMLS CUI [1,3]
C0008838
intermediate degree lymphoma derived from the malignant transformation of a previous low-grade lymphoma.
Descrizione

Intermediate-Grade Lymphoma Derived Malignant lymphoma unclassifiable low grade

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0079741
UMLS CUI [1,2]
C1441547
UMLS CUI [1,3]
C0854880
active infection (in the opinion of the investigator).
Descrizione

Communicable Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009450
Ritorna all'inizio della pagina

Similar models

Eligibility Non-Hodgkin's Lymphoma NCT00491127

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Aggressive Non-Hodgkin Lymphoma | WHO tumor classification
Item
the patients must have a histological diagnosis of aggressive non-hodgkin’s lymphoma including the following sub-categories of the who classification:
boolean
C1332225 (UMLS CUI [1])
C1301142 (UMLS CUI [2])
Diffuse Large B-Cell Lymphoma | Immunoblastic Large-Cell Lymphoma | Burkitt-like lymphoma | Sclerosis Mediastinum | Mucosa-Associated Lymphoid Tissue Lymphoma | T-Cell Lymphoma | Anaplastic large B-cell lymphoma
Item
diffuse large b-cell lymphoma and its variants (immunoblastic, burkitt-like, sclerosis of mediastinum, large b-cell malt, rich in t-cells and anaplastic b-cell lymphoma)
boolean
C0079744 (UMLS CUI [1])
C0079746 (UMLS CUI [2])
C1368771 (UMLS CUI [3])
C0036429 (UMLS CUI [4,1])
C0025066 (UMLS CUI [4,2])
C0242647 (UMLS CUI [5])
C0079772 (UMLS CUI [6])
C1321546 (UMLS CUI [7])
Peripheral T-Cell Lymphoma
Item
peripheral t-cell lymphoma
boolean
C0079774 (UMLS CUI [1])
Large cell anaplastic lymphoma T cell and Null cell type
Item
anaplastic lymphoma of large t-cells /null cells
boolean
C3838707 (UMLS CUI [1])
chemotherapeutics regimen first line of treatment | Anthracyclines | rituximab | Disease Progression Evidence of | Refractory Disease
Item
patients are eligible if they have documented evidence of progression after prior first-line chemotherapy containing anthracyclines associated or not with rituximab. patients with refractory disease to first line of treatment are also eligible.
boolean
C2045825 (UMLS CUI [1])
C0282564 (UMLS CUI [2])
C0393022 (UMLS CUI [3])
C0242656 (UMLS CUI [4,1])
C0332120 (UMLS CUI [4,2])
C1514815 (UMLS CUI [5])
ECOG performance status
Item
ecog ps (performance status) less than or equal to 2
boolean
C1520224 (UMLS CUI [1])
Measurable Disease 2-Dimensional
Item
presence of bidimensionally measurable disease in accordance with who criteria.
boolean
C1513041 (UMLS CUI [1,1])
C1705052 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Central Nervous System Involvement
Item
involvement of the cns.
boolean
C4050309 (UMLS CUI [1])
Medical condition Contraindication Cisplatin
Item
any medical condition which contraindicates the degree of hydration required for the safe use of cisplatin.
boolean
C3843040 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
C0008838 (UMLS CUI [1,3])
Intermediate-Grade Lymphoma Derived Malignant lymphoma unclassifiable low grade
Item
intermediate degree lymphoma derived from the malignant transformation of a previous low-grade lymphoma.
boolean
C0079741 (UMLS CUI [1,1])
C1441547 (UMLS CUI [1,2])
C0854880 (UMLS CUI [1,3])
Communicable Disease
Item
active infection (in the opinion of the investigator).
boolean
C0009450 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial